KALA BIO appoints Todd Bazemore as permanent CEO; board election, updated compensation

KALA BIO, Inc.

Todd Bazemore appointed CEO effective Aug 29, 2025, replacing his interim CEO role; also elected Class II director.
Annual base salary increased to $655,000; target annual bonus set at 60% of salary.
Severance upon qualifying termination within 24 months of change of control: 24 months salary, 200% target bonus, plus benefits.
Granted option to purchase 180,000 shares of common stock, vesting monthly over 4 years at close price on grant date.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.